Safety Study of an Antimicrobial Peptide Lactocin 160, Produced by the Vaginal Lactobacillus rhamnosus
2007

Safety Study of Lactocin 160 from Lactobacillus rhamnosus

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): Sara E. Dover, Alla A. Aroutcheva, S. Faro, Michael L. Chikindas

Hypothesis

To evaluate the safety of the antimicrobial peptide, lactocin 160.

Conclusion

Lactocin 160 showed minimal irritation and has a good potential for intravaginal application.

Supporting Evidence

  • Lactocin 160 had an ET-50 value of 17.5 hours, indicating low toxicity.
  • The hemolytic activity of lactocin 160 was only 8.2%, much lower than the total hemolysis caused by nonoxynol-9.
  • Three-dimensional EpiVaginal tissue model showed similar results to in vivo testing.

Takeaway

Lactocin 160 is a substance made by good bacteria that helps keep the vagina healthy and doesn't cause irritation.

Methodology

In vitro and in vivo testing using EpiVaginal tissue model and rabbit vaginal irritation model.

Limitations

The study may not fully represent human responses due to differences between rabbit and human vaginal tissue.

Participant Demographics

Healthy female rabbits were used for the in vivo model.

Digital Object Identifier (DOI)

10.1155/2007/78248

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication